Curanex Pharmaceuticals (CURX) Times Interest Earned (2024 - 2025)

Curanex Pharmaceuticals' (CURX) quarterly Times Interest Earned came in at -$3.93 in Q3 2025, down 1070.71% on a QoQ basis from -$0.34 in Q2 2025.

Curanex Pharmaceuticals (CURX) Times Interest Earned (2024 - 2025) Analysis & Trends

Curanex Pharmaceuticals (CURX) has 2 years of Times Interest Earned data on file, last reported at -$3.93 in Q3 2025.

Quarterly Times Interest Earned changed N/A year-over-year to -$3.93 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$5.17 (changed N/A YoY) and the FY2025 annual result came in at -$4.17, down 48.48% from the prior year.
Times Interest Earned eased to -$3.93 in Q3 2025, from -$0.34 in the prior quarter.
In the past five years, Times Interest Earned ranged from a high of -$0.34 in Q2 2025 to a low of -$3.93 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Times Interest Earned (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	117.59
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	8.18
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	2.82
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	76.86
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-0.08
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	1.42
10	Curanex Pharmaceuticals	6.02 Mn	1.02 Mn	-	-

Download Data